Mullins J J, Ganten D
Centre for Genome Research, University of Edinburgh, UK.
J Hypertens Suppl. 1990 Dec;8(7):S35-7.
We have shown that it is possible to generate transgenic rats efficiently, allowing direct experimentation in this species, without first testing constructs in the mouse. Having developed the technology for producing transgenic rats, we now hope to generate new and precise models of hypertension and to test candidate genes that may be responsible for the phenotype in existing animal models. The potential to choose between the rat and the mouse for these studies will allow much greater flexibility in experimental design. Many molecular questions are more appropriately addressed in the mouse but questions concerning physiology and development of the cardiovascular system are more appropriately addressed in the rat. With a large number of genes relevant to cardiovascular research now available, transgenic technology will become increasingly important in the future, and even more so if homologous recombination becomes feasible in the rat. The transgenic rat therefore heralds an exciting new dimension in hypertension research.
我们已经表明,高效生成转基因大鼠是可能的,这使得可以直接在该物种中进行实验,而无需先在小鼠中测试构建体。在开发出生产转基因大鼠的技术后,我们现在希望生成新的、精确的高血压模型,并测试可能导致现有动物模型中该表型的候选基因。在这些研究中能够在大鼠和小鼠之间进行选择,将使实验设计具有更大的灵活性。许多分子问题在小鼠中研究更为合适,但有关心血管系统生理学和发育的问题在大鼠中研究更为合适。随着现在有大量与心血管研究相关的基因可用,转基因技术在未来将变得越来越重要,如果同源重组在大鼠中变得可行,其重要性甚至会更高。因此,转基因大鼠为高血压研究开创了一个令人兴奋的新领域。